Marcucci Gemma, Zimran Ari, Bembi Bruno, Kanis John, Reginster Jean-Yves, Rizzoli Renè, Cooper Cyrus, Brandi Maria Luisa
Head, Bone Metabolic Diseases Unit, Department of Surgery and Translational Medicine, University of Florence, Viale Pieraccini 6, 50139, Florence, Italy.
Calcif Tissue Int. 2014 Dec;95(6):477-94. doi: 10.1007/s00223-014-9923-y. Epub 2014 Nov 7.
Gaucher disease is a relatively rare metabolic disease caused by the inherited deficiency of the lysosomal enzyme glucocerebrosidase. Gaucher disease affects multiple organs, among which is the skeleton. Bone involvement occurs frequently in Gaucher disease, and is one of its most debilitating features, reducing the quality of life of patients. Bone status is an important consideration for treatment to ameliorate symptoms and reduce the risk of irreversible complications. We have conducted a systematic review of all the various aspects of Gaucher disease, focusing on different skeletal manifestations, pathophysiology of bone alterations, clinical symptoms, and current diagnostic and therapeutic approaches.
戈谢病是一种相对罕见的代谢性疾病,由溶酶体酶葡萄糖脑苷脂酶的遗传性缺乏引起。戈谢病会影响多个器官,骨骼是其中之一。骨骼受累在戈谢病中很常见,并且是其最使人衰弱的特征之一,会降低患者的生活质量。骨骼状况是治疗中改善症状和降低不可逆并发症风险的重要考虑因素。我们对戈谢病的各个方面进行了系统综述,重点关注不同的骨骼表现、骨骼改变的病理生理学、临床症状以及当前的诊断和治疗方法。